Sr One Capital Management, Lp Portfolio Stock Holdings
Sr One Capital Management, Lp disclosed 14 stock positions valued at approximately $915.4 million in its latest SEC 13F filing. The largest holdings include Arcellx, Inc., Design Therapeutics, Inc., and ORIC Pharmaceuticals, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 14
- Portfolio Value
- $915.4M
Holdings by Sector
Sr One Capital Management, Lp Portfolio Holdings in Q1 2026
10 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. | ACLX | Healthcare | 29.43% | 2,346,630 | - | - | $269,440,057 |
| Design Therapeutics, Inc. | DSGN | Healthcare | 7.59% | 6,526,476 | - | - | $69,441,704 |
| ORIC Pharmaceuticals, Inc. | ORIC | Healthcare | 6.39% | 4,514,929 | - | - | $58,476,915 |
| Alumis Inc. | ALMS | Healthcare | 4.72% | 1,959,896 | - | - | $43,176,509 |
| Mineralys Therapeutics Inc. | MLYS | Healthcare | 4.63% | 1,563,966 | - | - | $42,367,839 |
| ARS Pharmaceuticals, Inc. | SPRY | Healthcare | 3.52% | 4,012,903 | - | - | $32,223,611 |
| Oculis Holding AG | H5870P102 | Other | 1.86% | 641,022 | - | - | $17,044,775 |
| Nkarta, Inc. | NKTX | Healthcare | 0.77% | 3,333,333 | - | - | $7,033,333 |
| enGene Holdings Inc. | ENGN | Healthcare | 0.56% | 747,750 | - | - | $5,092,178 |
| Ultragenyx Pharmaceutical Inc. | RARE | Healthcare | 0.32% | 137,753 | - | - | $2,885,925 |